Skip to main content
iScience logoLink to iScience
. 2020 Sep 3;23(9):101525. doi: 10.1016/j.isci.2020.101525

Enzyme-Constrained Models and Omics Analysis of Streptomyces coelicolor Reveal Metabolic Changes that Enhance Heterologous Production

Snorre Sulheim 1,2, Tjaša Kumelj 2, Dino van Dissel 1, Ali Salehzadeh-Yazdi 3, Chao Du 4, Gilles P van Wezel 4, Kay Nieselt 5, Eivind Almaas 2,6, Alexander Wentzel 1, Eduard J Kerkhoven 7,8,9,
PMCID: PMC7501462  PMID: 32942174

Summary

Many biosynthetic gene clusters (BGCs) require heterologous expression to realize their genetic potential, including silent and metagenomic BGCs. Although the engineered Streptomyces coelicolor M1152 is a widely used host for heterologous expression of BGCs, a systemic understanding of how its genetic modifications affect the metabolism is lacking and limiting further development. We performed a comparative analysis of M1152 and its ancestor M145, connecting information from proteomics, transcriptomics, and cultivation data into a comprehensive picture of the metabolic differences between these strains. Instrumental to this comparison was the application of an improved consensus genome-scale metabolic model (GEM) of S. coelicolor. Although many metabolic patterns are retained in M1152, we find that this strain suffers from oxidative stress, possibly caused by increased oxidative metabolism. Furthermore, precursor availability is likely not limiting polyketide production, implying that other strategies could be beneficial for further development of S. coelicolor for heterologous production of novel compounds.

Subject Areas: Systems Biology, Omics, Metabolic Engineering

Graphical Abstract

graphic file with name fx1.jpg

Highlights

  • Time-series transcriptomics and proteomics of S. coelicolor M145 and M1152

  • Application of GEM to interpret changes in the proteome on the systems level

  • Limited effect of improved precursor supply on enhanced production in M1152

  • Reduced rate of germicidin in M1152 suggests a need for other expression hosts


Systems Biology; Omics; Metabolic Engineering

Introduction

The bacterium Streptomyces coelicolor has been the de facto model actinomycete for the production of antibiotics. Being known for over 100 years, the interest in this organism predates the golden age of antibiotic research. With its complex life cycle, featuring mycelial growth and differentiation, spore formation, programmed cell death, and the ability to produce multiple colored secondary metabolites, it has assisted greatly in our understanding of how streptomycetes sense their surrounding (Hahn et al., 2002; Hutchings et al., 2004; Nothaft et al., 2010; Rigali et al., 2008; Sola-Landa et al., 2005), activate their developmental cycle (Chandra and Chater, 2014), and regulate the production of antibiotics (Nieselt et al., 2010; Thomas et al., 2012). Further aided by the publication of its genome sequence (Bentley et al., 2002), the antibiotic coelimycin P1 (yellow), produced from the formerly cryptic polyketide gene cluster known as cpk, was added to this list (Gomez-Escribano et al., 2012). Today, the widespread use of S. coelicolor continues as a host for heterologous production of biosynthetic gene clusters (BGCs) (Castro et al., 2015; Gomez-Escribano and Bibb, 2011, 2014; Kumelj et al., 2019; Thanapipatsiri et al., 2015; Yin et al., 2015). Heterologous expression is a powerful strategy for novel compound discovery from BGCs that are either natively silent or originate from an unculturable source (Nepal and Wang, 2019). These BGCs represent an untapped resource of microbial biodiversity, nowadays made evident and accessible due to recent advances within the fields of metagenomics, molecular biology, and bioinformatics (Rutledge and Challis, 2015).

The efficiency of S. coelicolor as a heterologous production host relies on a metabolism that has evolved to provide the necessary precursors to produce a broad range of complex molecules. Many of these molecules are produced when the strain is experiencing nutrient-limiting conditions that lead to growth cessation and complex re-modelling of its metabolism (Wentzel et al., 2012a). Metabolic switching in response to phosphate and glutamate depletion has been studied in detail at a variety of metabolic levels in S. coelicolor M145 (Nieselt et al., 2010; Thomas et al., 2012; Wentzel et al., 2012b), the most well-known wild-type strain devoid of the two plasmids SCP1 and SCP2 present in the parent strain S. coelicolor A3(2) (Kieser et al., 2000). This has unraveled a complex sequence of switching events that ultimately lead to the biosynthesis of calcium-dependent antibiotic (CDA), and the colored antibiotics actinorhodin (Act, blue) and undecylprodigiosin (Red, red). The biosynthesis of coelimycin P1 occurs earlier than the three other compounds in the growth cycle and appears to be independent of the major metabolic switch (Nieselt et al., 2010).

To improve S. coelicolor M145 as a host for heterologous BGC expression, strain M1146 was created by the sequential deletion of its four major BGCs (act, red, cda, and cpk) (Gomez-Escribano and Bibb, 2011). This should increase precursor availability for the production of a whole range of heterologous products and provides a cleaner chromatographic background to more easily identify novel compounds. S. coelicolor M1152 is a derivative of M1146, which besides the deletion of the four main BGCs bears the C1298T point mutation in the rpoB gene that encodes the beta subunit of RNA polymerase. This mutation was shown to have strong positive effects on the production of various antibiotics (Gomez-Escribano and Bibb, 2011; Hu et al., 2002). Up to now, M1152 is a preferred general “superhost” for heterologous BGC expression (Braesel et al., 2019; Castro et al., 2015; Kepplinger et al., 2018; Li et al., 2013; Thanapipatsiri et al., 2015) and is the starting point for further strain development.

Previous research on the metabolism of S. coelicolor M1152 has been confined to transcriptome profiling of batch fermentations (Battke et al., 2010; Jager et al., 2011; Liao et al., 2014; Love et al., 2014; Mi et al., 2019), and further development of this strain as a “superhost” calls for a better understanding of how the genetic modifications have affected the regulatory system and metabolism of M1152. To this end we measure both protein and transcript levels of both M1152 and its parent strain, M145, at different time steps during batch fermentation where the metabolic switch is triggered by depletion of phosphate. As enzymes are catalyzing most metabolic transformations, assessing protein abundance provides information about the metabolic capacity of the organism. Furthermore, we do not only consider the protein abundances in isolation but also use these measurements to confine fluxes predicted by a genome-scale metabolic model (GEM) of S. coelicolor to the maximum capacity of the enzymes. By doing so we propagate differences in the abundance of individual enzymes in M145 and M1152 to metabolic rearrangements on the systems level.

The metabolic network in the cell is described in a GEM (Gu et al., 2019). GEMs are valuable resources of strain-specific knowledge, mathematical models able to predict steady-state flux distributions, and frameworks for interpretation and integration of different “omics” data, e.g., transcriptomics and proteomics (Robinson and Nielsen, 2016). The increased interest in using genome-scale models of S. coelicolor is conspicuous. Since the first reconstruction in 2005 (Borodina et al., 2005) five GEMs have been published (Alam et al., 2010; Amara et al., 2018; Kim et al., 2014; Kumelj et al., 2019; Wang et al., 2018), including three in 2018: iKS1317 (Kumelj et al., 2019), Sco4 (Wang et al., 2018), and iAA1259 (Amara et al., 2018). In addition, as a model organism for the Actinomycetes, the GEMs of S. coelicolor are frequently used as template for model development of closely related strains (Mohite et al., 2019), such as Streptomyces clavuligerus (Toro et al., 2018), Saccharopolyspora erythraea (Licona-Cassani et al., 2012) and Streptomyces lividans (Valverde et al., 2018). The recent updates of the S. coelicolor GEM were developed in parallel by different research groups: although all groups share the common interest of utilizing a high-quality model for predictions and data analysis, the prevailing approach of independent parallel development is inefficient. In addition to duplicating a considerable amount of work, lack of common standards for documentation of progress and issues, evaluation of model performance, as well as the use of different annotations makes it cumbersome to compare and merge models.

To increase the rate and quality of model reconstruction, in this study two research groups of the S. coelicolor GEM community, responsible for two of the latest model updates (Kumelj et al., 2019; Wang et al., 2018), have joined forces to merge existing GEMs of S. coelicolor into one consensus model that is publicly hosted on GitHub and can be continuously updated and improved by all members of the community. Hosting the model on GitHub has many advantages: (1) open access and contribution, (2) version control, (3) continuous development and integrated quality control with memote (Lieven et al., 2020), (4) new improvements released instantly (no publication lag time), and (5) complete documentation of model reconstruction. Such an approach has historic precedents: model reconstruction as a community effort has been a success for the human GEM (Thiele et al., 2013), baker's yeast (Aung et al., 2013; Dobson et al., 2010; Heavner et al., 2012, 2013; Herrgard et al., 2008; Lu et al., 2019), and Chinese hamster ovary cells (Hefzi et al., 2016). The recent developments in S. coelicolor model and strain improvements in different research groups prove that it is an opportune time now to join forces in the Streptomyces modeling efforts as well.

Results

Reconstruction of the Consensus Genome-Scale Model of S. Coelicolor

We conducted a stepwise reconstruction of Sco-GEM, the consensus genome-scale metabolic model of S. coelicolor, while tracking development using Git for version control (Figure 1A, Data S1, Table 1). Sco-GEM is the most comprehensive and highest quality GEM of this organism (Figure 1B), comprising 1,777 genes, 2,612 reactions, 2,073 metabolites, and a memote score of 77%, which is indicative of the overall model quality (Lieven et al., 2020). Sco-GEM features an accuracy of 96.5% and 74.5% (Figure 1C) in predicting correct phenotypes for growth environments and knockout mutants, respectively, yielding in total a Matthews coefficient of correlation of 0.53 with the test data previously described (Kumelj et al., 2019).

Figure 1.

Figure 1

Sco-GEM Development and Analysis

(A) Schematic overview of the various steps in the Sco-GEM reconstruction process.

(B) The overall memote score and number of genes, reactions, and metabolites for the seven published S. coelicolor GEMs.

(C) Assessment of the model quality by comparing in vivo observations with in silico predictions across in total 241 tests: accuracy = 0.80; sensitivity = 0.96; specificity = 0.48; Matthews correlation coefficient = 0.53.

(D) The change in Gibbs free energy for 770 reactions that were annotated as either reversible or forward (i.e., forward irreversible) in the model before curation of reaction reversibility. The histogram is truncated at −105 kJ/mol, and more negative values are assigned to the leftmost bin.

(E) Analysis and comparison of the directionality and reversibility of reactions before curation and the direction inferred from the change in Gibbs free energy as estimated by eQuilibrator. Reactions labeled “forward” or “backward” are irreversible.

(F) Overview of the 369 transport reactions included in Sco-GEM, whereof 42 were curated and 65 were added during this work. The inner ring categorizes the reactions into nine different subgroups, whereas the outer ring displays the amount of curated and added reactions within each category. In the outer ring, the sections representing curated and new reactions are hatched and dotted, respectively.

(G) Comparison of cumulative flux variability distributions in Sco-GEM and EcSco-GEM.

With the recently published iKS1317 model (Kumelj et al., 2019) as a starting point, Sco-GEM was first developed by including genes, reactions, and metabolites from the equally recently published models iAA1259 (Amara et al., 2018) and Sco4 (Wang et al., 2018). The curations from iAA1259 were primarily related to coelimycin P1, butyrolactone, xylan, and cellulose pathways, whereas the 377 reactions added to Sco-GEM from Sco4 were scattered across a large range of different subsystems, covering both primary and secondary metabolism (Figure S1). Subsequent to merging the existing S. coelicolor GEMs, we performed a number of further curations of the model (Figure 1A): including improvement of annotations, both in terms of coverage and number of different databases, e.g., KEGG (Kanehisa, 2000; Kanehisa et al., 2019), BioCyC (Karp et al., 2019), ChEBI (Hastings et al., 2016), and MetaNetX (Moretti et al., 2016). All reactions and metabolites have been given identifiers according to the BiGG namespace (King et al., 2016), and all reactions are categorized into 15 different subsystems, covering 128 different pathways.

The biomass composition was curated to reflect estimated levels of prosthetic groups that are associated to cellular proteins. Proteomics data, as discussed later, were used to estimate protein levels, while UniProt (The UniProt Consortium, 2019) provided annotations of proteins with prosthetic groups, which was used to estimate overall prosthetic group levels (Data S1, Table 2).

Reaction Reversibility Updated for Almost a Third of Queried Reactions

The determination of reaction directionality and reversibility is an important step in a GEM reconstruction (Thiele and Palsson, 2010). However, the thermodynamic consistency of reactions was not considered in previous S. coelicolor models. We calculated Gibbs free energy changes for 770 of the 2,612 model reactions (Data S1, Table 3) using eQuilibrator (Flamholz et al., 2012) and found hardly any consistency between the calculated change in Gibbs free energy and the reversibility previously assigned to the model reactions (Figure 1D). To address this issue we decided to reassign the reversibility of the model reactions by using a relatively lenient threshold of −30 kJ/mol to classify a reaction as irreversible (Bar-Even et al., 2012; Feist et al., 2007), with the intent not to over-constrain the model (Figure 1E). The proposed changes in reversibility were evaluated against growth and knockout data (Kumelj et al., 2019), discarding 61 of the 332 proposed reactions, and consequentially, the flux bounds of 271 reactions were modified (see Transparent Methods). In addition, all ATP-driven reactions were manually curated and generally assumed irreversible unless they had an estimated positive change in Gibbs free energy or were known to be reversible. Examples of this include nucleoside diphosphate kinase (Chakrabarty, 1998) and ATP synthase (Yoshida et al., 2001). The manual curation of ATP-driven reactions led to a change in reversibility for 56 reactions.

Curation of Transport Reactions

As transport reactions have previously not been extensively curated in S. coelicolor models, we performed a thorough curation of transporters by querying various databases and BLAST analysis as detailed in Methods. This culminated in adding 43 new transport reactions and updating 39 of the 262 existing reactions in Sco-GEM (Figure 1F; Data S1, Table 4). The majority of the transporters comprise primary active transport proteins and secondary carriers (46%), in accordance with previous work (Getsin et al., 2013). Most primary active transporters are ATP-binding cassette (ABC) transporters (30%), whereas proton symports (30%) dominate the secondary carriers.

Development of the Enzyme-Constrained Model EcSco-GEM

To include explicit constraints regarding enzymes catalyzing metabolic reactions, the GECKO formalism (Sanchez et al., 2017) was applied to consider that catalyzing capacity is constrained by enzyme turnover rates (kcat) and abundances. The GECKO toolbox modifies the structure of an existing GEM to integrate turnover rates and proteome data. Consequentially, this constrains the range of estimated fluxes to a biologically feasible range as determined by the amount and efficiency of each enzyme. Note that this approach regards the maximum catalytic activities but does not consider other kinetic parameters such as affinity constants. The overall flux variability of the resulting enzyme-constrained model (EcSco-GEM) is drastically reduced compared with the classic genome-scale model (Figure 1G), particularly due to the considerably reduced fraction of reactions that have very high (101) flux variability. As reactions with high variability result in low certainty in the estimated fluxes, the observed reduction in flux variability is therefore a qualitative measure of the increased accuracy achieved by constraining the range of possible fluxes to those satisfying the limitation in protein allocation.

In our endeavor to describe the metabolic differences between M145 and M1152 we generated in total 17 time- and strain-specific enzyme-constrained models by combining EcSco-GEM with estimated growth, secretion, and uptake rates, as well as proteome data from cultivations that are detailed and analyzed later in the article.

Framework for Further Development of Sco-GEM by the Community

The Sco-GEM model is hosted as an open repository as suggested by memote, a recently developed tool for transparent and collaborative model development (Lieven et al., 2020). The memote tool is incorporated in the repository through Travis CI and tracks the model development on every change of the model. Sco-GEM v1.2.0 achieved a memote score of 77%, which is superior to that achieved by any previous model of S. coelicolor (Figure 1B; Supplemental Information).

Hosting Sco-GEM on GitHub with memote integration ensures continuous quality control and enables public insight into all aspects of model reconstruction and curation: any user can report errors or suggest changes through issues and pull requests. As contributions to the model development are fully trackable and can therefore be credited fairly, Sco-GEM is positioned as a community model that we envision to be continuously updated and widely used by the S. coelicolor research community. Although the major steps of model reconstruction have been detailed in the preceding sections, every detail of the process and every iteration of the model is accessible on the public model repository at https://github.com/SysBioChalmers/Sco-GEM.

In the remaining parts of the Results section, we have applied Sco-GEM along with transcriptome and proteome data, to study and compare the responses of S. coelicolor M145 and M1152 to phosphate depletion on a systems level and for the first time provide detailed insight into the distinct physiological features of engineered “superhost” strain M1152, which will be of value for its further development.

Random Sampling of Enzyme-Constrained GEMs Capture Metabolic Rearrangements in Response to Phosphate Depletion in M145

To evaluate whether the (Ec)Sco-GEM models can simulate behaviors of S. coelicolor metabolism, we analyzed time course sampled cultivations of secondary metabolite-producing strain M145 using the generated models. For this purpose, S. coelicolor M145 was cultivated in batch fermentations using standardized protocols reported earlier (Wentzel et al., 2012a). Cultures were sampled for “omics” data, as well as substrate utilization and secondary metabolite measurements to identify regulatory, proteomic, and metabolic changes during the metabolic switch. The online and offline measurements showed that phosphate depletion in the cultivation medium was reached approximately 35 h after inoculation. Shortly after, the culture growth ceased, and first Red and subsequently Act were detected in the culture medium (Figures 2A and 2B). Act levels were determined by measuring the amount of total blue pigments because this covers both the intracellular and secreted variants of actinorhodin, and is considered to be the preferred method (Bystrykh et al., 1996; Wentzel et al., 2012a). Both D-glucose and L-glutamate were consumed concomitantly, and their consumption continued after phosphate depletion, whereas both remained in excess until the end of cultivation. Note that Streptomyces can utilize intracellular phosphate storages after the medium is phosphate depleted (Smirnov et al., 2015). The RNA sequencing (RNA-seq) and untargeted proteomic data were analyzed in the light of previous studies (Nieselt et al., 2010; Thomas et al., 2012) and were in good agreement with data previously obtained from microarrays or targeted proteomics (Alam et al., 2010; Nieselt et al., 2010) (Figures 2C and S2). This confirmed the high reproducibility of the experiments across independent cultivations and high reliability of the chosen cultivation and analytic procedures (Figure 2).

Figure 2.

Figure 2

Batch Cultivation of S. Coelicolor M145 and the Effect of Phosphate Depletion

(A and B) Compounds produced (A) and consumed (B) during batch fermentation of S. coelicolor M145. Time points for sampling for transcriptome and proteome analysis are indicated with red triangles. The dashed vertical line indicates when phosphate in the medium has been depleted. Error bars are standard deviations of three biological replicates. CDW, cell dry weight; Red, undecylprodigiosin; TBP, total blue pigments/actinorhodins; CO2, volume-corrected respiration; D-Glc, D-glucose; L-Glu, L-glutamate; PO4, phosphate.

(C) Comparison of previously published microarray data (Nieselt et al., 2010) and RNA-seq data (this study) for genes previously found to respond to phosphate depletion (Nieselt et al., 2010). The transparent lines correspond to individual genes, whereas the bold lines represent the average expression level for each dataset.

(D) Clustered heatmap of CO2-normalized Z scores for each of the top 10 varying pathways plus the pathways for the four major BGCs in M145, as revealed by simulations with the proteomics-integrated EcSco-GEM model. The pathways are sorted based on hierarchical clustering to facilitate visual interpretation of similarity between pathways. The dashed vertical line indicates the time point of the metabolic switch.

(E) RNA-seq data of the four major BGCs show the onset of biosynthesis of actinorhodin (Act), calcium-dependent antibiotic (CDA), coelimycin P1 (Cpk), and undecylprodigiosin (Red) at different time points during the batch fermentations of M145.

The proteome data and calculated uptake/secretion rates (Table S1) were incorporated into EcSco-GEM to yield time-specific metabolic models of M145, giving insight on the changes occurring in the metabolic activity of different pathways during batch cultivation. Metabolic fluxes were estimated using an unbiased approach of random sampling, as alternative to optimization of a well-defined cellular objective used in flux balance analysis (Orth et al., 2010). It is possible that S. coelicolor is wired to maximize its growth rate before phosphate depletion, but after the metabolic switch, it is difficult to define a clear cellular objective. We applied an approach that samples the vertices of the solution space (Bordel et al., 2010) and used their mean values to compare the metabolic fluxes between the two strains and between different time points. The variation in predicted fluxes through different pathways in M145 is an initial validation of the approach (Figure 2D): the most drastic change in fluxes occur in response to phosphate depletion, in agreement with observations in the transcriptome, metabolome, and proteome (Nieselt et al., 2010; Thomas et al., 2012; Wentzel et al., 2012b).

The response to phosphate depletion from the medium is achieved by a set of genes, positively regulated by PhoP, that are involved in phosphate scavenging, uptake, and saving (Martin et al., 2012; Martin-Martin et al., 2018; Sola-Landa et al., 2003). In our cultivations the metabolic switch can be readily identified from the RNA-seq data by the rapid upregulation of this regulon after 35 h of cultivation in M145 (Figure 2C), thereby corroborating the model simulations (Figure 2D) and providing a more detailed picture of the underlying regulation. PhoP also represses nitrogen assimilation (Martin et al., 2017), which can partly explain the change in amino acids metabolism after phosphate depletion (Figure 2D). Indeed, from the RNA-seq data we find that glutamate import, the glutamate sensing system gluR-gluK (Li et al., 2017), glnR (Fink et al., 2002), and glnA are downregulated immediately subsequent to phosphate depletion (Figure S3). As PhoP is also known to regulate negatively the biosynthesis of secondary metabolites, the switching of its expression likely delays these pathways (Martin, 2004; Martin et al., 2017). However, after 37 h of cultivation the upregulation of the cda and red genes was observed, whereas that of the act genes was initiated at 41 h (Figure 2E). Production of Red and Act was measurable in the culture medium after 41 and 49 h of cultivation, respectively (Figure 2A). The enzyme-constrained models predict an immediate increase in fluxes through the biosynthetic pathways for the four main compounds Act, Red, CDA, and coelimycin P1 after the metabolic switch (Figure 2D).

The Onset of Secondary Metabolism Is Strongly Correlated with an Increase in Oxidative Phosphorylation and a Decrease in Fatty Acid Biosynthesis in M145

The metabolic switch was shown to be correlated with an enhanced degradation of branched-chain amino acids (valine, leucine, and isoleucine), an increase in oxidative phosphorylation, and a decrease in fatty acid biosynthesis (Figures 2D and S4). An active oxidative phosphorylation relies on an active tricarboxylic acid (TCA) cycle that generates reduced co-factors whose re-oxidation by the respiratory chain generates a proton gradient that drives ATP synthesis by the ATP synthase. The feeding of the TCA cycle requires acetyl-CoA, as well as nitrogen. Nitrogen likely originates from degradation of glutamate and branched-chain amino acids, whereas acetyl-CoA likely originates from glycolysis, as well as from the degradation of these amino acids as previously demonstrated (Stirrett et al., 2009). Indeed, the model predicts an increased flux through citrate synthase feeding acetyl-CoA into the TCA cycle (Figure S5A). The predicted increase in oxidative phosphorylation is supported by the RNA-seq data showing upregulation of enzymes belonging to the respiratory chain (Figure S5B). This is consistent with the clear correlation previously reported between high ATP/ADP ratio, resulting from an active oxidative phosphorylation, and actinorhodin production (Esnault et al., 2017). Furthermore, the consumption of acetyl-CoA by the TCA cycle to support the oxidative metabolism logically impairs fatty acids biosynthesis (Esnault et al., 2017).

The pentose phosphate pathway provides the main redox cofactor NADPH for polyketide biosynthesis, as well as to combat oxidative stress, and its model-predicted flux increase upon initiation of polyketide synthesis (Figure 2D) is in agreement with previous studies (Borodina et al., 2008; Jonsbu et al., 2001). A clear positive correlation was also noticed between the biosynthesis of alanine, aspartate, and glutamate, which are precursors for CDA and/or coelimycin P1 (Figure 2D), and the biosynthesis of these antibiotics. Similar observations were made in the antibiotic-producing Amycolatopsis sp. (Gallo et al., 2010). Our EcSco-GEM model proved to be in good agreement with previously reported findings, indicating that it is able to capture S. coelicolor metabolic behavior.

Model-Assisted Characterization of Engineered S. Coelicolor M1152 and Its Responses to Phosphate Depletion

As detailed earlier, EcSco-GEM shed a new light on the metabolic switch in secondary metabolite-producing strain M145. S. coelicolor M1152 (Gomez-Escribano and Bibb, 2011) is an M145 derivative devoid of the four major BGCs and bearing a point mutation in the rpoB gene. A better systemic understanding of M1152 metabolism would benefit to its further development as a performing host. To do so, a comparative analysis of gene expression levels and metabolic fluxes was carried out in the strains M145 and M1152.

Batch cultivations of M1152 were performed using identical conditions and comparable sampling regimes as for M145 reported earlier. This enabled a direct comparison of the two strains at a systems level, revealing both expected and unexpected effects of the strains' genetic differences (Figure 3). As anticipated, the products of the Cpk, CDA, Red, and Act biosynthetic pathways were undetectable in M1152 (Figure 3A). As previously observed (Gomez-Escribano and Bibb, 2011), the growth rate of M1152 is reduced compared with M145 (0.15 h−1 versus 0.21 h−1 in the initial exponential growth phase), delaying phosphate depletion by M1152 to 47 h after inoculation (Figure 3B), 12 h after M145 (Figure 2B).

Figure 3.

Figure 3

Batch Cultivation of S. Coelicolor M1152

(A and B) Compounds produced (A) and consumed (B) during batch fermentation of S. coelicolor M1152. Time points for sampling for transcriptome and proteome analysis are indicated with red triangles. The dashed vertical line indicates when phosphate in the medium has been depleted. Error bars are standard deviations of three biological replicates. CDW, cell dry weight; Red, undecylprodigiosin; TBP, total blue pigments/actinorhodins; CO2, volume-corrected respiration; D-Glc, D-glucose; L-Glu, L-glutamate; PO4, phosphate.

(C) Alignment of sample time points of M145 and M1152 cultivations based on the expression profiles of genes that were earlier found to respond to phosphate depletion with respect to the metabolic switch (Nieselt et al., 2010).

(D) Principle-component analysis of the proteomics data for M145 (triangles) and M1152 (circles), for each time point and culture. The first principal component separates the time points, whereas the second principal component separates the two strains.

(E) CO2-normalized Z scores of pathway fluxes predicted by EcSco-GEM for 10 of the most varying pathways in M145 and M1152. To make this heatmap comparable to the results for M145 (Figure 2D), the data are standardized for both strains simultaneously and the row order is identical.

The sampling time points for proteome and transcriptome were adjusted accordingly (Figure 3B), enabling pairwise comparison of measurements between the two strains. Genes responsive to phosphate depletion, members of the PhoP regulon (Nieselt et al., 2010), were used to align the different sample datasets for M145 or M1152 (Figure 3C). Principle-component analysis of the proteome data confirms high consistency between corresponding biological replicates and incremental changes between sample points for both M145 and M1152 (mainly explained by principal component 1 (PC1): 18.6% variance, Figure 3E). A clear strain-dependent clustering of the data (PC2: 15.5% variance) indicates globally significant differences at the protein level. EcSco-GEM was subsequently used to create time-specific metabolic models from proteome data and estimated rates (Table S2) and predict metabolic changes in M1152. Interestingly we find that most patterns in M145 are retained in M1152 (Figure 3D): fatty acid and nucleotide biosynthesis is still downregulated after phosphate depletion, and similar trends of upregulation at later time points are observed for oxidative phosphorylation, glycine, serine and threonine, and pyruvate metabolism. It is striking that the upregulation of the branched-chain amino acid degradation and the alanine, aspartate, and glutamate metabolism seen as a response to phosphate depletion in M145 are absent in M1152.

The different glutamate and glucose consumption rates of M145 and M1152 (Figures 4A and 4B) resulted in substantial metabolic differences between the two strains before phosphate depletion. During cultivation on SSBM-P medium, where glutamate is the sole nitrogen source, glucose and glutamate are co-consumed. M1152, as M1146 (Esnault et al., 2017), has an increased growth yield on glucose compared with M145 (Figure S6). It thus obtains a larger share of its carbon from glutamate (Figures 4A and 4B) and has consequently also a higher nitrogen availability than M145. The increased nitrogen availability does, however, not increase the secretion of ammonium, indicating that the consumed nitrogen is directed toward growth or production of secondary metabolites. A reduced flux through glycolysis has also been reported previously for strain M1146 (Coze et al., 2013). This might be an effect of the predicted increased concentration of ATP in M1146 compared with M145, which inhibits glucose uptake and phosphofructokinase (Coze et al., 2013; Esnault et al., 2017). As Act was proposed to act as an electron acceptor reducing the efficiency of the oxidative phosphorylation, it is suggested that the lack of Act in M1146 causes the elevated ATP levels (Esnault et al., 2017). However, we find the largest difference in glycolytic flux at early time points, before phosphate depletion and Act production in M145, proving that Act itself cannot explain this observation.

Figure 4.

Figure 4

Predicted Carbon Fluxes in M145 and M1152

(A) The ratio between estimated uptake rates of glucose and glutamate for each sample time point for M145 and M145 shows that M1152 acquires a smaller part of its carbon from glucose compared with M145.

(B) Bar chart showing CO2-normalized fluxes for the second sampling time point for M145 and M1152, i.e., after 29 and 41 h, respectively. There is a clear difference in the uptake of glucose and production of acetate, whereas the rates are comparable for the consumption of glutamate and secretion of ammonium.

(C) Comparison of predicted fluxes for the second sampling time points shows clear differences between the two strains in their relative utilization of the glycolysis and TCA cycle. The strength of the color of the lines corresponds to the flux difference between the strains; green reactions have higher flux in M1152, and red reactions have higher flux in M145.

The EcSco-GEM predicts the consequences of the reduced glucose uptake of M1152 on its central carbon metabolism, as displayed by mapping relative reaction fluxes from the second sampling time point onto a map of the central carbon metabolism in Streptomyces (Figure 4C). The map is based on the reaction network in Sco-GEM and created using Escher (King et al., 2015). A less-active glycolysis in M1152 than in M145 leads to a lower carbon flow toward acetyl-CoA and thus lower excretion of acetate compared with M145 (Figure 4B). Furthermore, EcSco-GEM reveals an increased flux from glutamate to alpha-ketoglutarate. Indeed, a fraction of the pool of oxaloacetate might be converted into alpha-ketoglutarate by aspartate transaminase to feed the TCA cycle. The rest might be converted into phosphoenolpyruvate (PEP) by PEP carboxykinase for gluconeogenesis because PEP carboxykinase was shown to carry higher fluxes in M1152 than in M145 (Figure 4C).

As recent studies have demonstrated a negative correlation and a competition for common precursors between secondary metabolite and triacylglycerol (TAG) biosynthesis in S. lividans and S. coelicolor (Craney et al., 2012; Esnault et al., 2017; Millan-Oropeza et al., 2017), one can speculate that the acetyl-CoA/malonyl-CoA units yielded by glycolysis for the biosynthesis of antibiotics in M145 are being used for enhanced growth and/or fatty acids and TAG biosynthesis in M1152. However, this is likely not the case, as M1152 has rather a reduced growth rate compared with M145, and fatty acid biosynthesis remains downregulated after the switch (Figure 5). Malonyl-CoA is predominantly shuttled toward fatty acid biosynthesis through malonyl-CoA-ACP transacylase, and this consumption seems to be well balanced by the amount of malonyl-CoA produced by acetyl-CoA carboxylase. It is noteworthy that the flux toward this acetyl-CoA/malonyl-CoA drain is 3- to 6-fold larger than the total flux going into secondary metabolite biosynthesis, even after the metabolic switch. We thus propose that together with enhanced nitrogen availability, acetyl-CoA made available from the deletion of these BGCs is used to feed the TCA cycle to support the oxidative metabolism in M1152. This would generate oxidative stress whose toxic effects might be responsible for the growth delay of this strain.

Figure 5.

Figure 5

Production and Consumption of Malonyl-CoA as the Branching Point between Fatty Acid Biosynthesis and Production of Polyketides

Both panels display CO2-normalized fluxes for both M145 and M1152 for all sampling time points as predicted by EcSco-GEM. The left panel shows the sources of malonyl-CoA, namely, acetyl-CoA carboxylase (ACCOAT; blue) and acetyl-CoA carboxytransferase (ACCOAT_1; orange). We observe a downregulation of the malonyl-CoA production after the metabolic switch (between time points 3 and 4) in both strains. The right panel presents reactions consuming malonyl-CoA. The consumption is dominated by malonyl-CoA-ACP transacylase (MCOATA) leading to biosynthesis of fatty acids. The other drains for malonyl-CoA are the pathways encoded by the four major BGCs (Act, Cpk, Red, and CDA) in addition to biflaviolin synthase (THYDNAPS).

Transcriptome Analysis Reveals Differential Expression of Global Regulators

Although the proteome data are an integral part of the EcSco-GEM models, RNA-seq data were used to both verify the trends and to gain further insights into the regulatory changes that are not captured by the metabolic models. As the proteomic data, the RNA-seq data showed large global differences between M1152 and M145, revealing 499 differentially expressed genes with a significance threshold of p < 0.01.

Unsupervised clustering of the significantly changed genes reveal differences in regulatory systems related to redox regulation, signaling, and secondary metabolism. The significantly changed genes were clustered into seven groups with K-means clustering, with clusters 1–3 containing genes that are upregulated in M1152 compared with M145, and clusters 4–7 vice versa (Figure S7A; Data S2). A Gene Ontology (Ashburner et al., 2000; The Gene Ontology Consortium, 2019) enrichment analysis of the seven clusters was conducted to identify upregulated processes in each of the two strains (Figure S8, cf. Figure S7A).

The enriched processes upregulated in M1152 point to increased oxidative stress (Figure S8): antioxidant and peroxidase activity (SCO2633 [sodF]; SCO4834-35) in addition to biosynthesis of carotenoid (SCO0185–SCO0188), a known antioxidant (Latifi et al., 2009; Stahl and Sies, 2003). The putative proteins within the cytochrome-P450 family (SCO7416–SCO7422) found in cluster 1 might be linked not only to increased oxidative stress (Zangar et al., 2004) but also to oxidation of precursors used for the synthesis of macrolides (Lamb et al., 2003). Indeed, by comparing the time series expression levels for genes related to oxidative stress we observe that the majority of genes related to oxidative stress are upregulated in M1152 (Figure 6). These changes correlate to a more active oxidative metabolism, TCA cycle, and oxidative stress as predicted by Ec-ScoGEM (Figure 4).

Figure 6.

Figure 6

Heatmap Displaying Log-Transformed RNA-Seq Data of Genes Associated with Oxidative Stress

The genes included are related to oxidative stress and either present in Sco-GEM or within the 499 differentially expressed genes. These genes are categorized based on their functional annotation to distinguish differences and similarities between these functional groups. To further enhance visual interpretation the genes are ordered based on hierarchical clustering to align genes with similar expression profiles across M145 and M1152 next to each other.

In cluster 2 we find scbA (SCO6266) and its downstream gene scbC (SCO6267), which stands out by being almost 6-fold upregulated in M1152. This high expression level is likely due to the deletion of scbR2 (SCO6286), the last gene selected to be part of the cpk BGC (Bednarz et al., 2019). Besides regulation of the cpk cluster, ScbR2 binds upstream of several global regulators of development and secondary metabolism, including AfsK, SigR, NagE2, AtrA, AdpA, and ArgR (Li et al., 2015). It also acts together with ScbR to regulate ScbA, which produces the y-butyrolactone SCB1. However, when looking at the genes regulated by ScbR (Li et al., 2015), we only observe a clear difference in expression for genes regulated by AfsR (phosphorylated by AfsK) (Horinouchi, 2003; Lee et al., 2002), whereas this is not the case for genes regulated by ArgR, AdpA, or ScbR itself (Figures S5C-S5F).

Among the genes upregulated in M145, in cluster 4 we find genes related to the redox-regulated transcription factor SoxR (Naseer et al., 2014), and a similar pattern is observed for the entire SoxR regulon (Figure S7B). SoxR is known to react directly to the presence of actinorhodin (Dela Cruz et al., 2010; Shin et al., 2011), and indeed, in M145 this group of genes follows the production profile of actinorhodin, whereas their expression remains low in M1152 as Act is not produced. The benzoquinone Act, as electron acceptor, is thought to reduce respiration efficiency and thus energy charge, as well as to combat oxidative stress (Esnault et al., 2017). Consistently, the RNA-seq data revealed that the ATP-synthase gene cluster (SCO5366–SCO5374) was upregulated almost 2-fold in M1152 compared with M145, most prominently in the stationary phase during Act production (Figure S7C). This agrees with observations in the M1146 strain (Coze et al., 2013). Cluster 4 also contains the genes directly up- and downstream of the deleted actinorhodin BGC in M1152 (SCO5071–SCO5072, encoding 3-hydroxyacyl-CoA dehydrogenase, and SCO5091–SCO5092, encoding a two-component flavin-dependent monooxygenase system) (Valton et al., 2008). In clusters 5, 6, and 7 we find genes with reduced expression in M1152, and the enriched processes are related to cellular and iron ion homeostasis, development, signaling, and morphology. This corresponds to the delayed sporulation observed for M1152 (Gomez-Escribano and Bibb, 2011).

Elevated Expression of Ribosomal Proteins in M1152 after Phosphate Depletion

An increased transcription of genes encoding ribosomal proteins could be observed in M1152 after phosphate depletion (Figure S7D). The rpoB mutation of the RNA polymerase present in M1152 is thought to induce a conformational change mimicking the binding of guanosine tetraphosphate (ppGpp) to this enzyme (Hu et al., 2002). ppGpp is synthesized in response to nutritional stress and reduces the transcription of genes related to active growth, such as genes encoding ribosomal RNAs and ribosomal proteins (Burgos et al., 2017), whereas it upregulates those involved in development/differentiation and antibiotic production (Hesketh et al., 2007; Srivatsan and Wang, 2008). In consequence the upregulation of ribosomal proteins was unexpected in M1152, especially because the expression of the ppGpp regulon was not found to be significantly changed in M1152 (Figure S5G and S5H). We hypothesize that the ribosomal upregulation originates from the higher ATP content of M1152 compared with M145 post phosphate depletion, as high nucleoside triphosphate levels are known to have a positive impact on ribosome synthesis (Gaal et al., 1997). Such difference in ribosomal protein expression is mainly seen in the antibiotic production phase and correlated with production of Act in M145, which has a negative impact on the energetic state of the cell (Esnault et al., 2017).

Reduced Production of the Polyketide Germicidin in M1152

One could reasonably anticipate that the production of a secondary metabolite would increase if other drains competing for same precursor compounds were removed from the organism by gene deletion. However, the production rate of the polyketides germicidin A and B (Chemler et al., 2012), autologous to both M145 and M1152, were reduced in M1152 by 92% and 82% for germicidin A and B, respectively (Figure 7). This could be explained by the more active oxidative metabolism of M1152 compared with M145, as suggested by the enzyme-constrained model (Figure 4) and supported by the upregulation of genes associated with oxidative stress (Figure 6). In M1152 the pool of acetyl-CoA rather feeds the TCA cycle instead of being directed toward germicidin biosynthesis.

Figure 7.

Figure 7

Concentrations of Germicidin A and B Produced by M145, M1146, and M1152

The concentrations are normalized by the biomass of each strain. The shaded regions display the uncertainty range (±1 standard deviation) based on three replicate cultivations. Note that the growth rate is different between the strains, displayed by the vertical lines representing phosphate depletion at 35, 38, and 47 h for M145, M1146, and M1152, respectively.

To further elucidate the cause of the reduced production in M1152, we also measured germicidin production in the intermediate strain M1146 (Figures 7 and S7E), which does not feature the rpoB mutation but is missing the four BGCs also deleted in M1152 (Gomez-Escribano and Bibb, 2011). The production rate of germicidin A and B in M1146 was found to be reduced by 27% and 25%, respectively, compared with M145. When compared with the strong reduction in germicidin production that can be assigned to the rpoB mutation in M1152, removal of only the four BGCs in M1146 has a moderate effect on germicidin production. This conforms with the minor contribution of the BGCs compared with fatty acid biosynthesis on the total consumption of malonyl-CoA (Figure 5). Nonetheless, it remains contradictory that the removal of polyketide precursor drains negatively impacts the production of other polyketides.

Discussion

In this work, we carried out a multi-omics study to compare the metabolic changes of Streptomyces coelicolor M145 and the BGC deletion mutant M1152 during batch fermentation. The defined cultivation medium used in this work was chosen because it supports sufficient growth and a delayed, well-defined onset of secondary metabolism, necessary to study the metabolic switch (Wentzel et al., 2012a). We aimed at defining the metabolic features differing between the two strains, both during exponential growth and stationary phase after phosphate depletion.

To achieve this from a systems biology perspective, we combined time course sampled cultivation and transcriptome analysis with enzyme-constrained genome-scale models generated with proteome data. Such genome-scale models are extensively used to connect transcriptome and proteome data to metabolic fluxes. Leveraging metabolic simulations to contextualize transcriptional changes is mainly impacted by the quality of the computational model used. Here, two teams joined efforts to improve a consensus model of S. coelicolor, yielding a comprehensive model useful for the scientific community.

Genome-Scale Models Provide Hypothesis for Slow Growth of M1152

The reduced growth rate of M1152 is correlated with reduced glucose uptake and enhanced glutamate uptake compared with M145. This is expected to lead to a less active glycolysis but a more active TCA cycle, and thus, a more active oxidative metabolism in M1152 compared with M145. An active oxidative metabolism is known to generate oxidative stress, and indeed, the in vivo data, as well as the genome-scale model, predict an increased oxidative stress in M1152. The toxicity of oxidative stress might, at least in part, be responsible for the growth delay of M1152, whereas the rpoB mutation may add to this phenotype, because one of the functions of the ppGpp-associated RNA polymerase is to promote a growth arrest in conditions of nutritional stress.

Further Development May Improve M1152 as Host for Heterologous Expression

The strain M1152 has several advantages as a host for heterologous production of secondary metabolites. The deletion of the four major BGCs not only removes presumed competing drains for valuable precursors but also generates a clean background to ease the identification of novel products by mass spectrometry. M1152 has already been proved to be more efficient than M145 and M1146 in heterologous production of the nitrogen-containing antibiotics chloramphenicol and congocidine, as well as Act production from reintroduction of its BGC (Gomez-Escribano and Bibb, 2011). Strains M1146 and M1152 produce, respectively, 3- to 5-fold and 20- to 40-fold more chloramphenicol and congocidine from respective heterologous clusters than M145, a clear demonstration of the huge impact on production due to the rpoB mutation. Although this contrasts with our data showing that M1152 has the lowest production of germicidin, it is relevant to note that chloramphenicol and congocidine are non-ribosomal peptide synthases relying on amino acids rather than malonyl-CoA as precursors. Although our data show reduced degradation of branched-chain amino acids and metabolism of alanine, aspartate, and glutamate as the clearest metabolic divergence upon phosphate depletion in M1152, as congocidine and chloramphenicol are based on aromatic amino acids the connection to increased production of these NRPs is not obvious. Another option is that the increased oxidative metabolism in M1152 provides more redox cofactors to drive the synthesis of these molecules. If competition for valuable precursors was rate limiting, the absence of the polyketides actinorhodin and coelimycin P1 should at least enhance the production of germicidin, all being dependent on malonyl-CoA. Moreover, differences in cultivation media further convolute cross-study comparisons: the aforementioned study use a complex growth medium, whereas we used a defined medium with glucose and glutamate, which has previously been optimized for studying the metabolic switch (Wentzel et al., 2012a).

Furthermore, (re-)introduction of a (secondary) copy of germicidin synthase gene gcs in strains M1152 and M1317—derived from M1152 by additional removal of three type III PKS genes including gcs—gave a 7.8- and 10.7-fold increase in germicidin production, respectively, compared with M1152 with only the native copy of gcs (Thanapipatsiri et al., 2015). Thus, the largest increase in production is not achieved by removal of competing precursor drains, but rather effected by the re-introduction of gcs, probably because expression of the inserted gene is not constrained by the same regulatory mechanism as the native gene.

Although earlier work has suggested a competition for common precursors between fatty acids and secondary metabolites biosynthesis (Craney et al., 2012), our results suggest that other approaches than deletion of competing precursor drains may be more efficient in the development of an optimized expression host, and it seems likely that different classes of BGCs may require different hosts for maximal production. Our comparative analysis of M145 and M1152 supports this development, not only as a systemic description connecting non-trivial associations between phenotypic, genetic, and metabolic differences but also by highlighting cellular processes that seem to be out of balance in M1152. These include upregulation of ribosomal genes, most likely an effect of the rpoB mutation, and increased oxidative metabolism and oxidative stress. As Act itself works as an electron acceptor one may hypothesize that its presence could relieve some of this stress. Another approach is to reintroduce scbR2 to avoid influencing the related regulators of development and secondary metabolism.

Although S. coelicolor seems to have a complex and not fully elucidated regulatory system, several studies have shown that manipulation of regulatory genes can affect the production of secondary metabolites (Jones et al., 2011; Kim et al., 2003; Okamoto et al., 2003; Rodriguez et al., 2012). The complex regulation of secondary metabolite biosynthesis makes rational strain design difficult (Liu et al., 2013), but black-box approaches including random mutations and screening are still viable approaches for strain development (van den Berg et al., 2008; Crook and Alper, 2012). The Sco-GEM can aid this development by predicting the impact of these genetic alterations and to interpret “omics” data.

Limitations of the Study

We have performed a thorough comparison, of S. coelicolor M1145 and M1152, but to fully attribute changes in metabolism to the different genetic modifications as well as to unravel possible epistatic interactions we believe that a comprehensive analysis that also includes the intermediate strain M1146, and possibly also an M145 strain featuring only the rpoB mutation (Xu et al., 2002), will be necessary.

Resource Availability

Lead Contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Eduard J Kerkhoven (eduardk@chalmers.se).

Materials Availability

This study did not generate new unique reagents.

Data and Code Availability

The models and scripts generated during this study are available at GitHub (https://github.com/SysBioChalmers/Sco-GEM). Here, the latest version of the Sco-GEM is available in both YAML and SBML level 3 Version 1. In addition, users can contribute to further model development by posting issues or suggest changes. The proteomics data are available from ProteomeXchange: PXD013178 via the PRIDE partner repository (Perez-Riverol et al., 2019). Normalized proteome data are also available in Data S3. The transcriptomics data are available from NCBI GEO: GSE132487 (M145) and GSE132488 (M1152). Normalized counts are also found in Data S4.

Methods

All methods can be found in the accompanying Transparent Methods supplemental file.

Acknowledgments

The authors would like to acknowledge Bogdan I. Florea of Leiden University, Leiden, Netherlands, for running and monitoring the proteome measurements and the bio-organic synthesis group at Leiden University for providing the opportunity to use their instrumentation. The authors would also like to acknowledge co-workers at SINTEF Industry, Trondheim, Norway: Ingemar Nærdal, Anna Lewin, and Kari Hjelen for running the batch fermentations and Anna Nordborg, Janne Beate Øiaas, and Tone Haugen for performing offline analyses and the germicidin analytics. The RNA-seq sequencing was carried out by c.ATG, Tübingen, Germany.

This study was conducted in the frame of ERA-net for Applied Systems Biology (ERA-SysAPP) project SYSTERACT and the project INBioPharm of the Center for Digital Live Norway (Research Council of Norway grant no. 248885), with additional support of SINTEF internal funding.

Author Contributions

Conceptualization, E.J.K., E.A., A.W., S.S., A.S.-Y., and T.K.; Methodology and Software, E.J.K., S.S., A.S.-Y., and T.K; Validation and Formal Analysis, C.D., K.N., D.v.D., S.S., T.K., and E.J.K. Investigation, T.K., A.W., S.S., E.J.K.; Data Curation, S.S. and T.K.; Writing – Original Draft, S.S., T.K., D.V.D., C.D., and K.N.; Writing – Review & Editing, all authors; Visualization, S.S., E.K., C.D., and D.v.D.; Supervision, A.W., E.A., E.J.K., and G.P.v.W.; Project Administration, A.W.; Funding Acquisition: A.W., E.J.K., E.A., and G.P.v.W.

Declaration of Interests

The authors declare no competing interests.

Published: September 25, 2020

Footnotes

Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2020.101525.

Supplemental Information

Document S1. Transparent Methods, Figures S1–S10, and Tables S1 and S2
mmc1.pdf (4.8MB, pdf)
Data S1. Tables Presenting Key Information about the Model and the Model Reconstruction, Related to Figure 1
mmc2.xlsx (132.3KB, xlsx)
Data S2. Genes Present in the Seven Clusters Identified with K-Means Clustering of the Differentially Expressed Genes, Related to Figure 2, 3, and S7A
mmc3.xlsx (23.5KB, xlsx)
Data S3. Normalized Proteome Data for M145 and M1152, Related to Figure 1A and 3E

M145 is cultivated in F516-F518, whereas M1152 is cultivated in F519, F521 and F522. Re-index IDs corresponds to the strain, fermentation number (F516–F522), a unique number describing the experiment, and a numbering of the time points from 1 to 9 (P1–P9), i.e. the re-indexed ID M145_F516_P2 represents the second time

point of fermentation 516 with the strain M145. In the original IDs (row below) the p-number represents time after inoculation (in hours).

mmc4.xlsx (1.3MB, xlsx)
Data S4. Normalized RNA-Seq Data for All Six Fermenters, Related to Figure 2C, 2E, 3C, and 6

M145 is cultivated in F516-F518, whereas M1152 is cultivated in F519, F521 and F522. Re-index IDs corresponds to the strain, fermentation number (F516–F522), a unique number describing the experiment, and a numbering of the time points from 1 to 9 (P1–P9), i.e., the re-indexed ID M145_F516_P2 represents the second time

point of fermentation 516 with the strain M145. In the original IDs (row below) the p-number represents time after inoculation (in hours).

mmc5.xlsx (5.3MB, xlsx)

References

  1. Alam M.T., Merlo M.E., (stream) T.S.C., Hodgson D.A., Wellington E.M., Takano E., Breitling R. Metabolic modeling and analysis of the metabolic switch in Streptomyces coelicolor. BMC Genomics. 2010;11:202. doi: 10.1186/1471-2164-11-202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amara A., Takano E., Breitling R. Development and validation of an updated computational model of Streptomyces coelicolor primary and secondary metabolism. BMC Genomics. 2018;19:519. doi: 10.1186/s12864-018-4905-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000;25:25–29. doi: 10.1038/75556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aung H.W., Henry S.A., Walker L.P. Revising the Representation of fatty acid, glycerolipid, and glycerophospholipid metabolism in the consensus model of yeast metabolism. Ind. Biotechnol. 2013;9:215–228. doi: 10.1089/ind.2013.0013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bar-Even A., Flamholz A., Noor E., Milo R. Thermodynamic constraints shape the structure of carbon fixation pathways. Biochim. Biophys. Acta. 2012;1817:1646–1659. doi: 10.1016/j.bbabio.2012.05.002. [DOI] [PubMed] [Google Scholar]
  6. Battke F., Symons S., Nieselt K. Mayday--integrative analytics for expression data. BMC Bioinformatics. 2010;11:121. doi: 10.1186/1471-2105-11-121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bednarz B., Kotowska M., Pawlik K.J. Multi-level regulation of coelimycin synthesis in Streptomyces coelicolor A3(2) Appl. Microbiol. Biotechnol. 2019;103:6423–6434. doi: 10.1007/s00253-019-09975-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bentley S.D., Chater K.F., Cerdeño-Tárraga A.-M.A.-M., Challis G.L., Thomson N.R., James K.D., Harris D.E., Quail M.A., Kieser H., Harper D. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) Nature. 2002;417:141–147. doi: 10.1038/417141a. [DOI] [PubMed] [Google Scholar]
  9. van den Berg M.A., Albang R., Albermann K., Badger J.H., Daran J.-M., Driessen A.J.M., Garcia-Estrada C., Fedorova N.D., Harris D.M., Heijne W.H.M. Genome sequencing and analysis of the filamentous fungus Penicillium chrysogenum. Nat. Biotechnol. 2008;26:1161–1168. doi: 10.1038/nbt.1498. [DOI] [PubMed] [Google Scholar]
  10. Bordel S., Agren R., Nielsen J. Sampling the solution space in genome-scale metabolic networks reveals transcriptional regulation in key enzymes. PLOS Comput. Biol. 2010;6:e1000859. doi: 10.1371/journal.pcbi.1000859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Borodina I., Krabben P., Nielsen J. Genome-scale analysis of Streptomyces coelicolor A3(2) metabolism. Genome Res. 2005;15:820–829. doi: 10.1101/gr.3364705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Borodina I., Siebring J., Zhang J., Smith C.P., Keulen G.van, Dijkhuizen L., Nielsen J. Antibiotic overproduction in streptomyces coelicolor A3(2) mediated by phosphofructokinase deletion. J. Biol. Chem. 2008;283:25186–25199. doi: 10.1074/jbc.M803105200. [DOI] [PubMed] [Google Scholar]
  13. Braesel J., Tran T.A., Eustáquio A.S. Heterologous expression of the diazaquinomycin biosynthetic gene cluster. J. Ind. Microbiol. Biotechnol. 2019;46:1359–1364. doi: 10.1007/s10295-019-02187-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Burgos H.L., O’Connor K., Sanchez-Vazquez P., Gourse R.L. Roles of transcriptional and translational control mechanisms in regulation of ribosomal protein synthesis in Escherichia coli. J. Bacteriol. 2017;199:e00407-17. doi: 10.1128/JB.00407-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bystrykh L.V., Fernández-Moreno M.A., Herrema J.K., Malpartida F., Hopwood D.A., Dijkhuizen L. Production of actinorhodin-related “blue pigments” by Streptomyces coelicolor A3(2) J. Bacteriol. 1996;178:2238–2244. doi: 10.1128/jb.178.8.2238-2244.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Castro J.F., Razmilic V., Gomez-Escribano J.P., Andrews B., Asenjo J.A., Bibb M.J. Identification and heterologous expression of the chaxamycin biosynthesis gene cluster from streptomyces leeuwenhoekii. Appl. Environ. Microbiol. 2015;81:5820–5831. doi: 10.1128/AEM.01039-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chakrabarty A.M. Nucleoside diphosphate kinase: role in bacterial growth, virulence, cell signalling and polysaccharide synthesis. Mol. Microbiol. 1998;28:875–882. doi: 10.1046/j.1365-2958.1998.00846.x. [DOI] [PubMed] [Google Scholar]
  18. Chandra G., Chater K.F. Developmental biology of Streptomyces from the perspective of 100 actinobacterial genome sequences. FEMS Microbiol. Rev. 2014;38:345–379. doi: 10.1111/1574-6976.12047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chemler J.A., Buchholz T.J., Geders T.W., Akey D.L., Rath C.M., Chlipala G.E., Smith J.L., Sherman D.H. Biochemical and structural characterization of germicidin synthase: analysis of a type III polyketide synthase that employs acyl-ACP as a starter unit donor. J. Am. Chem. Soc. 2012;134:7359–7366. doi: 10.1021/ja2112228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Coze F., Gilard F., Tcherkez G., Virolle M.-J., Guyonvarch A. Carbon-flux distribution within streptomyces coelicolor metabolism: a comparison between the actinorhodin-producing strain M145 and its non-producing derivative M1146. PLoS One. 2013;8:e84151. doi: 10.1371/journal.pone.0084151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Craney A., Ozimok C., Pimentel-Elardo S.M., Capretta A., Nodwell J.R. Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism. Chem. Biol. 2012;19:1020–1027. doi: 10.1016/j.chembiol.2012.06.013. [DOI] [PubMed] [Google Scholar]
  22. Crook N., Alper H. John Wiley & Sons, Inc.; 2012. Classical Strain Improvement. Engineering Complex Phenotypes in Industrial Strains.http://Dx. Doi. Org/10.1002/9781118433034. Ch1 [Google Scholar]
  23. Dela Cruz R., Gao Y., Penumetcha S., Sheplock R., Weng K., Chander M. Expression of the Streptomyces coelicolor SoxR regulon is intimately linked with actinorhodin production. J. Bacteriol. 2010;192:6428–6438. doi: 10.1128/JB.00916-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Dobson P.D., Smallbone K., Jameson D., Simeonidis E., Lanthaler K., Pir P., Lu C., Swainston N., Dunn W.B., Fisher P. Further developments towards a genome-scale metabolic model of yeast. BMC Syst. Biol. 2010;4:145. doi: 10.1186/1752-0509-4-145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Esnault C., Dulermo T., Smirnov A., Askora A., David M., Deniset-Besseau A., Holland I.-B., Virolle M.-J. Strong antibiotic production is correlated with highly active oxidative metabolism in Streptomyces coelicolor M145. Sci. Rep. 2017;7:200. doi: 10.1038/s41598-017-00259-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Feist A.M., Henry C.S., Reed J.L., Krummenacker M., Joyce A.R., Karp P.D., Broadbelt L.J., Hatzimanikatis V., Palsson B.Ø. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol. Syst. Biol. 2007;3:121. doi: 10.1038/msb4100155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Fink D., Weißschuh N., Reuther J., Wohlleben W., Engels A. Two transcriptional regulators GlnR and GlnRII are involved in regulation of nitrogen metabolism in Streptomyces coelicolor A3(2) Mol. Microbiol. 2002;46:331–347. doi: 10.1046/j.1365-2958.2002.03150.x. [DOI] [PubMed] [Google Scholar]
  28. Flamholz A., Noor E., Bar-Even A., Milo R. eQuilibrator—the biochemical thermodynamics calculator. Nucleic Acids Res. 2012;40:D770–D775. doi: 10.1093/nar/gkr874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gaal T., Bartlett M.S., Ross W., Turnbough C.L., Gourse R.L. Transcription regulation by initiating NTP concentration: rRNA synthesis in bacteria. Science. 1997;278:2092–2097. doi: 10.1126/science.278.5346.2092. [DOI] [PubMed] [Google Scholar]
  30. Gallo G., Renzone G., Alduina R., Stegmann E., Weber T., Lantz A.E., Thykaer J., Sangiorgi F., Scaloni A., Puglia A.M. Differential proteomic analysis reveals novel links between primary metabolism and antibiotic production in Amycolatopsis balhimycina. Proteomics. 2010;10:1336–1358. doi: 10.1002/pmic.200900175. [DOI] [PubMed] [Google Scholar]
  31. Getsin I., Nalbandian G.H., Yee D.C., Vastermark A., Paparoditis P.C., Reddy V.S., Saier M.H. Comparative genomics of transport proteins in developmental bacteria: myxococcus xanthus and Streptomyces coelicolor. BMC Microbiol. 2013;13:279. doi: 10.1186/1471-2180-13-279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Gomez-Escribano J.P., Bibb M.J. Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microb. Biotechnol. 2011;4:207–215. doi: 10.1111/j.1751-7915.2010.00219.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Gomez-Escribano J.P., Bibb M.J. Heterologous expression of natural product biosynthetic gene clusters in Streptomyces coelicolor: from genome mining to manipulation of biosynthetic pathways. J. Ind. Microbiol. Biotechnol. 2014;41:425–431. doi: 10.1007/s10295-013-1348-5. [DOI] [PubMed] [Google Scholar]
  34. Gomez-Escribano J.P., Song L., Fox D.J., Yeo V., Bibb M.J., Challis G.L. Structure and biosynthesis of the unusual polyketide alkaloid coelimycin P1, a metabolic product of the cpk gene cluster of Streptomyces coelicolor M145. Chem. Sci. 2012;3:2716–2720. [Google Scholar]
  35. Gu C., Kim G.B., Kim W.J., Kim H.U., Lee S.Y. Current status and applications of genome-scale metabolic models. Genome Biol. 2019;20:121. doi: 10.1186/s13059-019-1730-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Hahn J.-S., Oh S.-Y., Roe J.-H. Role of OxyR as a peroxide-sensing positive regulator in streptomyces coelicolor A3(2) J. Bacteriol. 2002;184:5214–5222. doi: 10.1128/JB.184.19.5214-5222.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Hastings J., Owen G., Dekker A., Ennis M., Kale N., Muthukrishnan V., Turner S., Swainston N., Mendes P., Steinbeck C. ChEBI in 2016: improved services and an expanding collection of metabolites. Nucleic Acids Res. 2016;44:D1214–D1219. doi: 10.1093/nar/gkv1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Heavner B.D., Smallbone K., Barker B., Mendes P., Walker L.P. Yeast 5 – an expanded reconstruction of the Saccharomyces cerevisiae metabolic network. BMC Syst. Biol. 2012;6:55. doi: 10.1186/1752-0509-6-55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Heavner B.D., Smallbone K., Price N.D., Walker L.P. Version 6 of the consensus yeast metabolic network refines biochemical coverage and improves model performance. Database. 2013;2013:bat059. doi: 10.1093/database/bat059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Hefzi H., Ang K.S., Hanscho M., Bordbar A., Ruckerbauer D., Lakshmanan M., Orellana C.A., Baycin-Hizal D., Huang Y., Ley D. A consensus genome-scale reconstruction of Chinese hamster ovary cell metabolism. Cell Syst. 2016;3:434–443.e8. doi: 10.1016/j.cels.2016.10.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Herrgard M.J., Swainston N., Dobson P., Dunn W.B., Arga K.Y., Arvas M., Blüthgen N., Borger S., Costenoble R., Heinemann M. A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat. Biotechnol. 2008;26:1155–1160. doi: 10.1038/nbt1492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Hesketh A., Chen W.J., Ryding J., Chang S., Bibb M. The global role of ppGpp synthesis in morphological differentiation and antibiotic production in Streptomyces coelicolor A3(2) Genome Biol. 2007;8:R161. doi: 10.1186/gb-2007-8-8-r161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Horinouchi S. AfsR as an integrator of signals that are sensed by multiple serine/threonine kinases in Streptomyces coelicolor A3(2) J. Ind. Microbiol. Biotechnol. 2003;30:462–467. doi: 10.1007/s10295-003-0063-z. [DOI] [PubMed] [Google Scholar]
  44. Hu H., Zhang Q., Ochi K. Activation of antibiotic biosynthesis by specified mutations in the rpoB gene (encoding the RNA polymerase β subunit) of Streptomyces lividans. J. Bacteriol. 2002;184:3984–3991. doi: 10.1128/JB.184.14.3984-3991.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Hutchings M.I., Hoskisson P.A., Chandra G., Buttner M.J. Sensing and responding to diverse extracellular signals? Analysis of the sensor kinases and response regulators of Streptomyces coelicolor A3(2) Microbiology. 2004;150:2795–2806. doi: 10.1099/mic.0.27181-0. [DOI] [PubMed] [Google Scholar]
  46. Jager G., Battke F., Nieselt K. 2011 IEEE Symposium on Biological Data Visualization. BioVis; 2011. Tiala — time series alignment analysis; pp. 55–61. [Google Scholar]
  47. Jones G., Sol R.D., Dudley E., Dyson P. Forkhead-associated proteins genetically linked to the serine/threonine kinase PknB regulate carbon flux towards antibiotic biosynthesis in Streptomyces coelicolor. Microb. Biotechnol. 2011;4:263–274. doi: 10.1111/j.1751-7915.2010.00237.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Jonsbu E., Christensen B., Nielsen J. Changes of in vivo fluxes through central metabolic pathways during the production of nystatin by Streptomyces noursei in batch culture. Appl. Microbiol. Biotechnol. 2001;56:93–100. doi: 10.1007/s002530100613. [DOI] [PubMed] [Google Scholar]
  49. Kanehisa M. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30. doi: 10.1093/nar/28.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Kanehisa M., Sato Y., Furumichi M., Morishima K., Tanabe M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2019;47:D590–D595. doi: 10.1093/nar/gky962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Karp P.D., Billington R., Caspi R., Fulcher C.A., Latendresse M., Kothari A., Keseler I.M., Krummenacker M., Midford P.E., Ong Q. The BioCyc collection of microbial genomes and metabolic pathways. Brief. Bioinform. 2019;20:1085–1093. doi: 10.1093/bib/bbx085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Kepplinger B., Morton-Laing S., Seistrup K.H., Marrs E.C.L., Hopkins A.P., Perry J.D., Strahl H., Hall M.J., Errington J., Allenby N.E.E. Mode of action and heterologous expression of the natural product antibiotic vancoresmycin. ACS Chem. Biol. 2018;13:207–214. doi: 10.1021/acschembio.7b00733. [DOI] [PubMed] [Google Scholar]
  53. Kieser T., Bibb M.J., Buttner M.J., Chater K.F., Hopwood D.A. Norwich, UK: John Innes Foundation; 2000. Practical Streptomyces Genetics. [Google Scholar]
  54. Kim D.-J., Huh J.-H., Yang Y.-Y., Kang C.-M., Lee I.-H., Hyun C.-G., Hong S.-K., Suh J.-W. Accumulation of S-Adenosyl-l-Methionine enhances production of actinorhodin but inhibits sporulation in streptomyces lividans TK23. J. Bacteriol. 2003;185:592–600. doi: 10.1128/JB.185.2.592-600.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Kim M.W., Sang Yi J., Kim J.-N.J., Kim J.-N.J., Kim M.W., Kim B.-G.G. Reconstruction of a high-quality metabolic model enables the identification of gene overexpression targets for enhanced antibiotic production in streptomyces coelicolor A3(2) Biotechnol. J. 2014;9:1185–1194. doi: 10.1002/biot.201300539. [DOI] [PubMed] [Google Scholar]
  56. King Z.A., Dräger A., Ebrahim A., Sonnenschein N., Lewis N.E., Palsson B.O. Escher: a web application for building, sharing, and embedding data-Rich visualizations of biological pathways. PLOS Comput. Biol. 2015;11:e1004321. doi: 10.1371/journal.pcbi.1004321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. King Z.A., Lu J., Dräger A., Miller P., Federowicz S., Lerman J.A., Ebrahim A., Palsson B.O., Lewis N.E. BiGG Models: a platform for integrating, standardizing and sharing genome-scale models. Nucleic Acids Res. 2016;44:D515–D522. doi: 10.1093/nar/gkv1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Kumelj T., Sulheim S., Wentzel A., Almaas E. Predicting strain engineering strategies using iKS1317: a genome-scale metabolic model of Streptomyces coelicolor. Biotechnol. J. 2019;14:1800180. doi: 10.1002/biot.201800180. [DOI] [PubMed] [Google Scholar]
  59. Lamb D.C., Ikeda H., Nelson D.R., Ishikawa J., Skaug T., Jackson C., Omura S., Waterman M.R., Kelly S.L. Cytochrome P450 complement (CYPome) of the avermectin-producer Streptomyces avermitilis and comparison to that of Streptomyces coelicolor A3(2) Biochem. Biophys. Res. Commun. 2003;307:610–619. doi: 10.1016/s0006-291x(03)01231-2. [DOI] [PubMed] [Google Scholar]
  60. Latifi A., Ruiz M., Zhang C.-C. Oxidative stress in cyanobacteria. FEMS Microbiol. Rev. 2009;33:258–278. doi: 10.1111/j.1574-6976.2008.00134.x. [DOI] [PubMed] [Google Scholar]
  61. Lee P.-C., Umeyama T., Horinouchi S. afsS is a target of AfsR, a transcriptional factor with ATPase activity that globally controls secondary metabolism in Streptomyces coelicolor A3(2) Mol. Microbiol. 2002;43:1413–1430. doi: 10.1046/j.1365-2958.2002.02840.x. [DOI] [PubMed] [Google Scholar]
  62. Li T., Du Y., Cui Q., Zhang J., Zhu W., Hong K., Li W. Cloning, characterization and heterologous expression of the indolocarbazole biosynthetic gene cluster from marine-derived streptomyces sanyensis FMA. Mar. Drugs. 2013;11:466–488. doi: 10.3390/md11020466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Li X., Wang J., Li S., Ji J., Wang W., Yang K. ScbR- and ScbR2-mediated signal transduction networks coordinate complex physiological responses in Streptomyces coelicolor. Sci. Rep. 2015;5:14831. doi: 10.1038/srep14831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Li L., Jiang W., Lu Y. A novel two-component system, GluR-GluK, involved in glutamate sensing and uptake in streptomyces coelicolor. J. Bacteriol. 2017;199:e00097-17. doi: 10.1128/JB.00097-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Liao Y., Smyth G.K., Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–930. doi: 10.1093/bioinformatics/btt656. [DOI] [PubMed] [Google Scholar]
  66. Licona-Cassani C., Marcellin E., Quek L.-E., Jacob S., Nielsen L.K. Reconstruction of the Saccharopolyspora erythraea genome-scale model and its use for enhancing erythromycin production. Antonie van Leeuwenhoek. 2012;102:493–502. doi: 10.1007/s10482-012-9783-2. [DOI] [PubMed] [Google Scholar]
  67. Lieven C., Beber M.E., Olivier B.G., Bergmann F.T., Ataman M., Babaei P., Bartell J.A., Blank L.M., Chauhan S., Correia K. MEMOTE for standardized genome-scale metabolic model testing. Nat. Biotechnol. 2020;38:272–276. doi: 10.1038/s41587-020-0446-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Liu G., Chater K.F., Chandra G., Niu G., Tan H. Molecular regulation of antibiotic biosynthesis in streptomyces. Microbiol. Mol. Biol. Rev. 2013;77:112–143. doi: 10.1128/MMBR.00054-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Lu H., Li F., Sánchez B.J., Zhu Z., Li G., Domenzain I., Marcišauskas S., Anton P.M., Lappa D., Lieven C. A consensus S. cerevisiae metabolic model Yeast8 and its ecosystem for comprehensively probing cellular metabolism. Nat. Commun. 2019;10:1–13. doi: 10.1038/s41467-019-11581-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Martin J.F. Phosphate control of the biosynthesis of antibiotics and other secondary metabolites is mediated by the PhoR-PhoP system: an unfinished story. J. Bacteriol. 2004;186:5197–5201. doi: 10.1128/JB.186.16.5197-5201.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Martín J.F., Santos-Beneit F., Rodríguez-García A., Sola-Landa A., Smith M.C.M., Ellingsen T.E., Nieselt K., Burroughs N.J., Wellington E.M.H. Transcriptomic studies of phosphate control of primary and secondary metabolism in Streptomyces coelicolor. Appl. Microbiol. Biotechnol. 2012;95:61–75. doi: 10.1007/s00253-012-4129-6. [DOI] [PubMed] [Google Scholar]
  73. Martin J.F., Rodríguez-García A., Liras P. The master regulator PhoP coordinates phosphate and nitrogen metabolism, respiration, cell differentiation and antibiotic biosynthesis: comparison in Streptomyces coelicolor and Streptomyces avermitilis. J. Antibiot. 2017;70:534–541. doi: 10.1038/ja.2017.19. [DOI] [PubMed] [Google Scholar]
  74. Martin-Martin S., Rodríguez-García A., Santos-Beneit F., Franco-Domínguez E., Sola-Landa A., Martín J.F. Self-control of the PHO regulon: the PhoP-dependent protein PhoU controls negatively expression of genes of PHO regulon in Streptomyces coelicolor. J. Antibiot. 2018;71:113–122. doi: 10.1038/ja.2017.130. [DOI] [PubMed] [Google Scholar]
  75. Mi H., Muruganujan A., Ebert D., Huang X., Thomas P.D. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419–D426. doi: 10.1093/nar/gky1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Millan-Oropeza A., Henry C., Blein-Nicolas M., Aubert-Frambourg A., Moussa F., Bleton J., Virolle M.-J. Quantitative proteomics analysis confirmed oxidative metabolism predominates in streptomyces coelicolor versus glycolytic metabolism in streptomyces lividans. J. Proteome Res. 2017;16:2597–2613. doi: 10.1021/acs.jproteome.7b00163. [DOI] [PubMed] [Google Scholar]
  77. Mohite O.S., Weber T., Kim H.U., Lee S.Y. Genome-scale metabolic reconstruction of actinomycetes for antibiotics production. Biotechnol. J. 2019;14:1800377. doi: 10.1002/biot.201800377. [DOI] [PubMed] [Google Scholar]
  78. Moretti S., Martin O., Van Du Tran T., Bridge A., Morgat A., Pagni M. MetaNetX/MNXref – reconciliation of metabolites and biochemical reactions to bring together genome-scale metabolic networks. Nucleic Acids Res. 2016;44:D523–D526. doi: 10.1093/nar/gkv1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Naseer N., Shapiro J.A., Chander M. RNA-Seq analysis reveals a six-gene SoxR regulon in Streptomyces coelicolor. PLoS One. 2014;9:e106181. doi: 10.1371/journal.pone.0106181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Nepal K.K., Wang G. Streptomycetes: surrogate hosts for the genetic manipulation of biosynthetic gene clusters and production of natural products. Biotechnol. Adv. 2019;37:1–20. doi: 10.1016/j.biotechadv.2018.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Nieselt K., Battke F., Herbig A., Bruheim P., Wentzel A., Jakobsen Ø.M., Sletta H., Alam M.T., Merlo M.E., Moore J. The dynamic architecture of the metabolic switch in Streptomyces coelicolor. BMC Genomics. 2010;11:10. doi: 10.1186/1471-2164-11-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Nothaft H., Rigali S., Boomsma B., Swiatek M., McDowall K.J., van Wezel G.P., Titgemeyer F. The permease gene nagE2 is the key to N-acetylglucosamine sensing and utilization in Streptomyces coelicolor and is subject to multi-level control. Mol. Microbiol. 2010;75:1133–1144. doi: 10.1111/j.1365-2958.2009.07020.x. [DOI] [PubMed] [Google Scholar]
  83. Okamoto S., Lezhava A., Hosaka T., Okamoto-Hosoya Y., Ochi K. Enhanced expression of S-adenosylmethionine synthetase causes overproduction of actinorhodin in streptomyces coelicolor A3(2) J. Bacteriol. 2003;185:601–609. doi: 10.1128/JB.185.2.601-609.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Orth J.D., Thiele I., Palsson B.Ø.O. What is flux balance analysis? Nat. Biotech. 2010;28:245–248. doi: 10.1038/nbt.1614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Perez-Riverol Y., Csordas A., Bai J., Bernal-Llinares M., Hewapathirana S., Kundu D.J., Inuganti A., Griss J., Mayer G., Eisenacher M. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442–D450. doi: 10.1093/nar/gky1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Rigali S., Titgemeyer F., Barends S., Mulder S., Thomae A.W., Hopwood D.A., van Wezel G.P. Feast or famine: the global regulator DasR links nutrient stress to antibiotic production by Streptomyces. EMBO Rep. 2008;9:670–675. doi: 10.1038/embor.2008.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Robinson J.L., Nielsen J. Integrative analysis of human omics data using biomolecular networks. Mol. Biosyst. 2016;12:2953–2964. doi: 10.1039/c6mb00476h. [DOI] [PubMed] [Google Scholar]
  88. Rodriguez E., Navone L., Casati P., Gramajo H. Impact of malic enzymes on antibiotic and triacylglycerol production in streptomyces coelicolor. Appl. Environ. Microbiol. 2012;78:4571–4579. doi: 10.1128/AEM.00838-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Rutledge P.J., Challis G.L. Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nat. Rev. Microbiol. 2015;13:509–523. doi: 10.1038/nrmicro3496. [DOI] [PubMed] [Google Scholar]
  90. Sanchez B.J., Zhang C., Nilsson A., Lahtvee P.-J., Kerkhoven E.J., Nielsen J. Improving the phenotype predictions of a yeast genome-scale metabolic model by incorporating enzymatic constraints. Mol. Syst. Biol. 2017;13:935. doi: 10.15252/msb.20167411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Shin J.-H., Singh A.K., Cheon D.-J., Roe J.-H. Activation of the SoxR regulon in Streptomyces coelicolor by the extracellular form of the pigmented antibiotic actinorhodin. J. Bacteriol. 2011;193:75–81. doi: 10.1128/JB.00965-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Smirnov A., Esnault C., Prigent M., Holland I.B., Virolle M.-J. Phosphate homeostasis in conditions of phosphate proficiency and limitation in the wild type and the phoP mutant of streptomyces lividans. PLoS One. 2015;10:e0126221. doi: 10.1371/journal.pone.0126221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Sola-Landa A., Moura R.S., Martín J.F. The two-component PhoR-PhoP system controls both primary metabolism and secondary metabolite biosynthesis in Streptomyces lividans. Proc. Natl. Acad. Sci. U S A. 2003;100:6133–6138. doi: 10.1073/pnas.0931429100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Sola-Landa A., Rodríguez-García A., Franco-Domínguez E., Martín J.F. Binding of PhoP to promoters of phosphate-regulated genes in Streptomyces coelicolor: identification of PHO boxes. Mol. Microbiol. 2005;56:1373–1385. doi: 10.1111/j.1365-2958.2005.04631.x. [DOI] [PubMed] [Google Scholar]
  95. Srivatsan A., Wang J.D. Control of bacterial transcription, translation and replication by (p)ppGpp. Curr. Opin. Microbiol. 2008;11:100–105. doi: 10.1016/j.mib.2008.02.001. [DOI] [PubMed] [Google Scholar]
  96. Stahl W., Sies H. Antioxidant activity of carotenoids. Mol. Aspects Med. 2003;24:345–351. doi: 10.1016/s0098-2997(03)00030-x. [DOI] [PubMed] [Google Scholar]
  97. Stirrett K., Denoya C., Westpheling J. Branched-chain amino acid catabolism provides precursors for the Type II polyketide antibiotic, actinorhodin, via pathways that are nutrient dependent. J. Ind. Microbiol. Biotechnol. 2009;36:129–137. doi: 10.1007/s10295-008-0480-0. [DOI] [PubMed] [Google Scholar]
  98. Thanapipatsiri A., Claesen J., Gomez-Escribano J.-P., Bibb M., Thamchaipenet A. A Streptomyces coelicolor host for the heterologous expression of Type III polyketide synthase genes. Microb. Cell Fact. 2015;14:145. doi: 10.1186/s12934-015-0335-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. The Gene Ontology Consortium The gene ontology resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47:D330–D338. doi: 10.1093/nar/gky1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. The UniProt Consortium UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47:D506–D515. doi: 10.1093/nar/gky1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Thiele I., Palsson B.Ø. A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat. Protoc. 2010;5:93–121. doi: 10.1038/nprot.2009.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Thiele I., Swainston N., Fleming R.M.T., Hoppe A., Sahoo S., Aurich M.K., Haraldsdottir H., Mo M.L., Rolfsson O., Stobbe M.D. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 2013;31:419–425. doi: 10.1038/nbt.2488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Thomas L., Hodgson D.A., Wentzel A., Nieselt K., Ellingsen T.E., Moore J., Morrissey E.R., Legaie R., STREAM Consortium T.S., Wohlleben W. Metabolic switches and adaptations deduced from the proteomes of Streptomyces coelicolor wild type and phoP mutant grown in batch culture. Mol. Cell. Proteomics. 2012;11 doi: 10.1074/mcp.M111.013797. M111.013797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Toro L., Pinilla L., Avignone-Rossa C., Ríos-Estepa R. An enhanced genome-scale metabolic reconstruction of Streptomyces clavuligerus identifies novel strain improvement strategies. Bioproc. Biosyst. Eng. 2018;41:657–669. doi: 10.1007/s00449-018-1900-9. [DOI] [PubMed] [Google Scholar]
  105. Valton J., Mathevon C., Fontecave M., Nivière V., Ballou D.P. Mechanism and regulation of the two-component FMN-dependent monooxygenase ActVA-ActVB from streptomyces coelicolor. J. Biol. Chem. 2008;283:10287–10296. doi: 10.1074/jbc.M709730200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Valverde J.R., Gullón S., Mellado R.P. Modelling the metabolism of protein secretion through the Tat route in Streptomyces lividans. BMC Microbiol. 2018;18:59. doi: 10.1186/s12866-018-1199-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Wang H., Marcišauskas S., Sánchez B.J., Domenzain I., Hermansson D., Agren R., Nielsen J., Kerkhoven E.J. Raven 2.0: a versatile toolbox for metabolic network reconstruction and a case study on Streptomyces coelicolor. PLOS Comput. Biol. 2018;14:e1006541. doi: 10.1371/journal.pcbi.1006541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Wentzel A., Bruheim P., Øverby A., Jakobsen Ø.M., Sletta H., Omara W.A.M., Hodgson D.A., Ellingsen T.E. Optimized submerged batch fermentation strategy for systems scale studies of metabolic switching in Streptomyces coelicolor A3(2) BMC Syst. Biol. 2012;6:59. doi: 10.1186/1752-0509-6-59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Wentzel A., Sletta H., Consortium S., Ellingsen T.E., Bruheim P. Intracellular metabolite pool changes in response to nutrient depletion induced metabolic switching in streptomyces coelicolor. Metabolites. 2012;2:178–194. doi: 10.3390/metabo2010178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Xu J., Tozawa Y., Lai C., Hayashi H., Ochi K. A rifampicin resistance mutation in the rpoB gene confers ppGpp-independent antibiotic production in Streptomyces coelicolor A3(2) Mol. Gen. Genomics. 2002;268:179–189. doi: 10.1007/s00438-002-0730-1. [DOI] [PubMed] [Google Scholar]
  111. Yin J., Hoffmann M., Bian X., Tu Q., Yan F., Xia L., Ding X., Francis Stewart A., Müller R., Fu J. Direct cloning and heterologous expression of the salinomycin biosynthetic gene cluster from Streptomyces albus DSM41398 in Streptomyces coelicolor A3(2) Sci. Rep. 2015;5:15081. doi: 10.1038/srep15081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Yoshida M., Muneyuki E., Hisabori T. ATP synthase — a marvellous rotary engine of the cell. Nat. Rev. Mol. Cell Biol. 2001;2:669–677. doi: 10.1038/35089509. [DOI] [PubMed] [Google Scholar]
  113. Zangar R.C., Davydov D.R., Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 2004;199:316–331. doi: 10.1016/j.taap.2004.01.018. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Document S1. Transparent Methods, Figures S1–S10, and Tables S1 and S2
mmc1.pdf (4.8MB, pdf)
Data S1. Tables Presenting Key Information about the Model and the Model Reconstruction, Related to Figure 1
mmc2.xlsx (132.3KB, xlsx)
Data S2. Genes Present in the Seven Clusters Identified with K-Means Clustering of the Differentially Expressed Genes, Related to Figure 2, 3, and S7A
mmc3.xlsx (23.5KB, xlsx)
Data S3. Normalized Proteome Data for M145 and M1152, Related to Figure 1A and 3E

M145 is cultivated in F516-F518, whereas M1152 is cultivated in F519, F521 and F522. Re-index IDs corresponds to the strain, fermentation number (F516–F522), a unique number describing the experiment, and a numbering of the time points from 1 to 9 (P1–P9), i.e. the re-indexed ID M145_F516_P2 represents the second time

point of fermentation 516 with the strain M145. In the original IDs (row below) the p-number represents time after inoculation (in hours).

mmc4.xlsx (1.3MB, xlsx)
Data S4. Normalized RNA-Seq Data for All Six Fermenters, Related to Figure 2C, 2E, 3C, and 6

M145 is cultivated in F516-F518, whereas M1152 is cultivated in F519, F521 and F522. Re-index IDs corresponds to the strain, fermentation number (F516–F522), a unique number describing the experiment, and a numbering of the time points from 1 to 9 (P1–P9), i.e., the re-indexed ID M145_F516_P2 represents the second time

point of fermentation 516 with the strain M145. In the original IDs (row below) the p-number represents time after inoculation (in hours).

mmc5.xlsx (5.3MB, xlsx)

Data Availability Statement

The models and scripts generated during this study are available at GitHub (https://github.com/SysBioChalmers/Sco-GEM). Here, the latest version of the Sco-GEM is available in both YAML and SBML level 3 Version 1. In addition, users can contribute to further model development by posting issues or suggest changes. The proteomics data are available from ProteomeXchange: PXD013178 via the PRIDE partner repository (Perez-Riverol et al., 2019). Normalized proteome data are also available in Data S3. The transcriptomics data are available from NCBI GEO: GSE132487 (M145) and GSE132488 (M1152). Normalized counts are also found in Data S4.


Articles from iScience are provided here courtesy of Elsevier

RESOURCES